Active · per the CBE, 16 September 2026

COOPMED

BE0841076904

Rechtspersoon Public limited company 1 establishment

COOPMED is filed with the CBE under the catch-all “Overige financiële dienstverlening”, a code that says little about what the company actually does. Public Limited, started on 16 November 2011, 1 establishment.

Gachardstraat 88 box 7, 1050 Elsene

Active for

14 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Negative equity NBB

    More debt than assets in 3 of the last 4 fiscal years.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 32 % of short-term debt in 2025; threshold 65 %.

  • Busy address KBO

    75 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

COOPMED from Elsene, company number BE0841076904, closed financial year 2025 with a result of € -24,488 after tax. For that financial year COOPMED recorded a gross margin of € 50,721 and equity of € -938,232. Compared with financial year 2024, the result moved from € -440,394 to € -24,488. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Caution

€ -938,232

▼ € 24,488 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -24,488

▲ 94 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 335,630

▼ 78% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -5.3 million.

Debts at end 2025

Bank debt

€ 1.2 million

▼ 58% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 65,038

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -191,867 € -200,565 € 2,329,643 € 50,721 ▼ 98%
Profit after taxes € -679,198 € -510,921 € -440,394 € -24,488 ▲ € 415,906
Equity € 37,570 € -473,351 € -913,745 € -938,232 ▼ € 24,488
Total debts € 11,239,741 € 7,510,940 € 3,009,055 € 1,245,745 ▼ 59%
Cash € 3,182,104 € 1,642,457 € 1,532,841 € 335,630 ▼ 78%
Retained profit € -4,312,430 € -4,823,351 € -5,263,745 € -5,288,232
Bank debt € 10,700,000 € 7,000,000 € 2,750,000 € 1,150,000 ▼ 58%
Balance sheet total € 11,277,311 € 7,037,589 € 2,351,210 € 385,413 ▼ 84%

Key figures of COOPMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to COOPMED?

What happened at COOPMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • NATHALIE LIBERT stepped down as director. NBB
  • ENEKO LANDABURU stepped down as director. NBB
  • DANY MAKLOUF stepped down as director. NBB
  • MARC BUISSON stepped down as director. NBB
  • LUCRECE MBONGO stepped down as director. NBB
  • SIDI stepped down as director. NBB
  • GABRIELE GIUGLIETTI stepped down as director. NBB
  • PATRICE RICCI stepped down as director. NBB

In short

From € 679,198 loss in 2022 to € 24,488 loss in 2025.

Paid € 11,204 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

A new publication or filing at COOPMED? We notify you, reason included.

Follow COOPMED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

CREDIT COOPERATIF 49.2%
SIDI 11.5%
GROUPE UP 6.9%
SOFICATRA 6.9%
+9
COOPMED

The shares are held by CREDIT COOPERATIF (49.2%), SIDI (11.5%), GROUPE UP (6.9%), SOFICATRA (6.9%), MUTAC (4.6%) and APS BANK (4.6%).

See the full network in the app

Directors

According to the 2025 annual accounts

NATHALIE LIBERT

Director

Also active at: COOPEST

since 2024 · until 2028

ENEKO LANDABURU

Chairman of the board

since 2024 · until 2028

DANY MAKLOUF

Director

Also active at: COOPEST

since 2024 · until 2028

MARC BUISSON

Director

since 2024 · until 2028

LUCRECE MBONGO

Director

since 2024 · until 2028

SIDI

Director · represented by CATHERINE BELLIN-SCHULZ

Also active at: FEDERATION EUROPEENNE DE FINANCES ET BANQUES ETHIQUES ET ALTERNATIVES

since 2024 · until 2028

GABRIELE GIUGLIETTI

Director

since 2024 · until 2028

PATRICE RICCI

Director

since 2024 · until 2028

Shareholders

CREDIT COOPERATIF

49.2%

SIDI

11.5%

GROUPE UP

6.9%

SOFICATRA

6.9%

MUTAC

4.6%

APS BANK

4.6%

ECOFI

4.1%

BANCA ETICA

2.8%

ESFIN

2.3%

PHITRUST

2.3%

MUTUELLE DE FRANCE

2.3%

SEFEA

1.4%

CASSA PADANA

1.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Gachardstraat 88 box 7

1050 Elsene

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 75 companies are registered at this address.

All companies at this address →

Casteau Homes

Prevent, Instituut voor Preventie en Welzijn op het Werk

Association des Chefs de Service de Securité et d'Hygiène de Belgique - Vereniging van Diensthoofden voor veiligheid en Hygiëne van België

Centre de Prévention du Suicide

€ 103,939 revenue · 2025

EFMD

€ 6.3 million revenue · 2025

+70 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0841.076.904
VAT number
BE 0841.076.904
Registered office
Gachardstraat 88 bus 7, 1050 Elsene
Names & denominations
COOPMED
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
16 November 2011
Peppol
Active · Active since 15 Sept 2025
Activities · NACE

Overige financiële dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does COOPMED do?
COOPMED is filed with the CBE under the catch-all “Overige financiële dienstverlening”, a code that says little about what the company actually does. Public Limited, started on 16 November 2011, 1 establishment.
What is the address of COOPMED?
The registered office of COOPMED is located at Gachardstraat 88 box 7, 1050 Elsene.
Is COOPMED still active?
Yes. According to the CBE (16 September 2026) COOPMED is active, legal situation “Normale toestand”, started on 16 November 2011.
Is COOPMED registered on Peppol?
Yes, COOPMED is registered on the Peppol network with ID 0208:0841076904.
What is the enterprise number of COOPMED?
The enterprise number of COOPMED is BE0841076904.
When was COOPMED founded?
COOPMED was founded on 16 November 2011.